#1
#1 out of 1
health1d ago
This CEO wants to cover weight loss drugs for employees. They're just too expensive.
- Jefferson Health says GLP-1 drug costs now drive a large share of its insurance expenses, challenging its budget.
- Jefferson has started restricting GLP-1 coverage, requiring diet programs before approval to curb costs.
- National trends show many large employers tightening access to GLP-1 medications amid rising spending.
- Novo Nordisk will cut Wegovy’s price in half starting in 2027, a move the company says helps affordability.
- Eli Lilly is pursuing programs to lower costs for employers and plan sponsors.
- Industry analysts say GLP-1 drugs can offer long-term savings despite higher upfront costs.
- Insurers report net prices for GLP-1 drugs vary after discounts, complicating budgeting for employers.
- Some workers report wanting rapid weight loss, prompting discussions about GLP-1 use in workplaces.
- Industry observers note GLP-1 drugs target a wide range of conditions beyond obesity.
- Experts caution that short-term use and off-label demand affect payers and health systems.
- The debate continues on who should bear the cost of GLP-1 medications now and in the future.
Vote 0